Fauchi is likely to approve another vaccine within two weeks

Washington-ALsharqiya January 24: White House adviser and chief epidemiologist in the United States, Anthony Fauchi, said that the vaccine that Johnson & Johnson is developing will be approved within a period not exceeding two weeks. The Johnson & Johnson vaccine is distinguished from the Pfizer and Moderna vaccines in that it consists of a single dose, while the other vaccines require two doses with an interval of up to six weeks. Johnson & Johnson expects to release 100 million doses of its vaccine by next April.


The Twitter platform announced the opening of live voice chat rooms,

A full year after theaters closed in Italy

The Directorate of Combating Terrorism in the Kurdistan Region announced that